Neumora Therapeutics
NMRA
NMRA
134 hedge funds and large institutions have $852M invested in Neumora Therapeutics in 2024 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
4% more call options, than puts
Call options by funds: $64.8M | Put options by funds: $62.2M
6% less capital invested
Capital invested by funds: $906M → $852M (-$54M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
134
Holding in Top 10
3
Calls
$64.8M
Puts
$62.2M
Top Buyers
| 1 | +$36.4M | |
| 2 | +$34.3M | |
| 3 | +$19M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$14.2M |
| 5 |
BlackRock
New York
|
+$9.75M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$10.7M | |
| 3 | -$8.9M | |
| 4 |
O
OrbiMed
New York
|
-$7.37M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.3M |